G1 Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

G1 Therapeutics, a commercial-stage oncology company, will have CEO Jack Bailey participate in the 20th Annual Needham Virtual Healthcare Conference on April 14, 2021, at 12:45 PM EDT. This event will be held virtually, and the webcast can be accessed via the company's Events & Presentations page. G1 is focused on developing innovative cancer therapies, including COSELA™ (trilaciclib), and has a strong pipeline targeting various solid tumors such as colorectal, breast, lung, and bladder cancers.

RESEARCH TRIANGLE PARK, N.C., April 07, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1’s Chief Executive Officer Jack Bailey will participate in the 20th Annual Needham Virtual Healthcare Conference. The fireside chat will take place on April 14th at 12:45 PM EDT. This meeting is being held virtually, and a live webcast will be accessible on the Events & Presentations page of http://www.g1therapeutics.com.

About G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product COSELA™ (trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

Contacts:
Will Roberts
Vice President, Investor Relations & Corporate Communications
919-907-1944
wroberts@g1therapeutics.com

FAQ

When is GTHX's participation in the Needham Virtual Healthcare Conference?

G1 Therapeutics, or GTHX, will participate in the Needham Virtual Healthcare Conference on April 14, 2021.

Who will represent GTHX at the conference?

CEO Jack Bailey will represent G1 Therapeutics at the conference.

What time is the GTHX fireside chat during the conference?

The fireside chat for GTHX is scheduled for 12:45 PM EDT.

Where can I watch the GTHX conference webcast?

The webcast for G1 Therapeutics' conference participation will be available on their Events & Presentations page.

What are GTHX's main focuses in oncology?

G1 Therapeutics focuses on developing therapies for various cancers, including treatments for colorectal, breast, lung, and bladder cancers.